End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
900 KRW | +2.51% | -24.24% | -5.16% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Trial Agency Services
58.1
%
| 3,034 | 67.5 % | 2,715 | 58.1 % | -10.52% |
Clinical Laboratory Animals Goods
22.3
%
| 1,462 | 32.5 % | 1,042 | 22.3 % | -28.71% |
Manufactured Product
19.7
%
| - | - | 919 | 19.7 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 4,496 | 100.0 % | 4,676 | 100.0 % | +4.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Young-Jun Son
CEO | Chief Executive Officer | 52 | - |
Young-Gil Lee
DFI | Director of Finance/CFO | 63 | - |
Sang-Cheol Lee
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Jun Son
CEO | Chief Executive Officer | 52 | - |
Young-Gil Lee
DFI | Director of Finance/CFO | 63 | - |
Sang-Cheol Lee
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Chang-Gi Heo
BRD | Director/Board Member | 49 | - |
Sang-Hwan Hyeon
BRD | Director/Board Member | 53 | - |
Ik-Jin Yoon
BRD | Director/Board Member | 62 | - |
Hyun-Woo Lee
BRD | Director/Board Member | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,716,352 | 4,142,352 ( 72.46 %) | 0 | 72.46 % |
Stock B | 0 | 638,295 | 0 | 0 |
Company contact information
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-5.16% | 2.07M | |
+6.73% | 19.67B | |
+26.12% | 4.32B | |
+32.02% | 2.94B | |
-9.67% | 1.64B | |
-1.45% | 847M | |
-15.25% | 778M | |
-30.58% | 773M | |
0.00% | 75.31M | |
-4.97% | 72.7M |
- Stock Market
- Equities
- A215570 Stock
- Company Cronex Co., Ltd.